Ozempic and Other GLP-1 Agonists May Cut Cancer Risk in Obese Patients, Study Finds

Discover how Ozempic and other GLP-1 agonists may reduce the risk of obesity-associated cancers in a recent study of obese patients. Learn more about the potential cancer-preventive effects of these diabetes medications.

Read More

Step Count or Time? New Study Suggests Both Equally Beneficial for Health

Discover how both step and time-based exercise goals equally reduce risks of early death and cardiovascular disease, according to a new study from Brigham and Women’s Hospital published in JAMA Internal Medicine. Learn more about the benefits of physical activity and how to choose the best goal for your health.

Read More